Drugs / LY2599506
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01029795 | Feb → Jun 2010 | type 2 diabetes mellitus | Eli Lilly and Company | Terminated | No outcome recorded |
| Phase 2 | NCT01024244 | Dec 2009 → Jul 2010 | type 2 diabetes mellitus | Eli Lilly and Company | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY2599506 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01024244 ↗ |
| Action | Activate | “Glucokinase Activator” NCT01024244 ↗ |
| Route | Oral | “Administered po for 12 weeks” NCT01024244 ↗ |